GUARD THERAPEUTICS INT.AB

Share · SE0021181559 · A3E2EN (XFRA)

No Price

03.11.2025 16:29

Current Prices from GUARD THERAPEUTICS INT.AB

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ STOCKHOLM AB	GUARD.ST	SEK	03.11.2025 16:29	1,38 SEK	-0,20 SEK -12,70 %

Share Float & Liquidity

Free Float 48,15 %

Shares Float 9,71 M

Shares Outstanding 20,17 M

Company Profile for GUARD THERAPEUTICS INT.AB Share

Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in October 2019. Guard Therapeutics International AB (publ) was incorporated in 2008 and is based in Stockholm, Sweden.

Get up to date insights from finAgent about GUARD THERAPEUTICS INT.AB

Company Data

Name GUARD THERAPEUTICS INT.AB

Company Guard Therapeutics International AB (publ)

Website https://guardtherapeutics.com

Primary Exchange

Frankfurt

WKN A3E2EN

ISIN SE0021181559

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Tobias Larsson Agervald

Market Capitalization 32 Mio

Country Sweden

Currency EUR

Employees 0,0 T

Address Nybrogatan 34, 2 tr, 114 39 Stockholm

IPO Date 2013-04-03

Ticker Symbols

Name	Symbol
NASDAQ STOCKHOLM AB	GUARD.ST
Frankfurt	5LH0.F

More Shares

Investors who hold GUARD THERAPEUTICS INT.AB also have the following shares in their portfolio:

AUTOZONE 23/26 Bond

SIGMA FINANCE CORPORATION (DO NOT PROCESS LINE REMOVALS / REDEMPTIONS) FLTG RTE NTS 30/07/13 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog